New pill aims to calm painful skin flares in rare sun allergy disease
Symptom relief
Recruiting now
This study tests an oral drug called ATL-001 (ciclopirox) in 6 adults with congenital erythropoietic porphyria (CEP), a rare disease that causes severe skin damage from sunlight. The goal is to see if the drug reduces skin lesions, fatigue, and other symptoms. Participants will b…
Phase: PHASE1, PHASE2 • Sponsor: Atlas Molecular Pharma • Aim: Symptom relief
Last updated May 04, 2026 03:16 UTC